Previous studies have correlated the Herlitz junctional epidermolysis bullosa (H-JEB) to an altered expression of the basement membrane component nicein/kalinin. This heterotrimeric glycoprotein appears to be present in H-JEB tissues in an abnormal form, because a number of antibodies specific to the protein either do not react with or weakly stain the epidermal basement membranes of most of the patients. With cDNA probes encoding each subunit of nicein and polyclonal antibodies raised against bacterial fusion polypeptides corresponding to the individual chains of the protein, we have molecularly analyzed the expression of nicein in H-JEB tissues and cultured keratinocytes. By immunohistochemistry, Northern blot, and protein analysis, we show a defective synthesis of one of the nicein subunits in six cases of H-JEB from five different consanguineous families. In two patients, the disease correlates with an impaired synthesis of the nicein B2 (nic B2) chain, in three others with that of the B1 (nic B1) chain, and in a sixth patient with that of the heavy A (nic A) chain. In this report, we thus demonstrate that H-JEB is a genetically heterogeneous disease and we provide strong evidence that the genes of nicein are the candidates for this genodermatosis. 
Introduction
Hereditary epidermolysis bullosa (EB)' is a group ofblistering skin diseases characterized by tissue separation within the dermal-epidermal basement membrane zone (1, 2) . In the simplex forms ofEB, intraepidermal tissue separation occurs at the level of basal keratinocytes ( 1 ) . The different clinical manifestations of EB simplex have been recently attributed to mutations on the genes encoding keratins 5 and 14, which are ex-Receivedfor publication 30 August 1993 and pressed by basal keratinocytes (3) (4) (5) . In the dystrophic scarring forms of EB, the cleavage occurs within the papillary dermis, below the basal lamina at the level of the anchoring fibrils ( 1 ) .
Several lines of evidence identified type VII collagen, the main component of anchoring fibrils, as the candidate gene for dystrophic EB (6, 7) . Subsequent genetic analysis of affected kindreds and the identification of point mutations in the collagen VII DNA sequences strongly support the involvement of the gene in the pathology (8) (9) (10) . The junctional forms of EB (JEB) result from tissue separation within the lamina lucida of the dermal-epidermal basement membrane. Several varieties of JEB have been described (1) . The (11 ) .
HD are cellular structures that appear as electron microscope thickenings making connection with intermediate filaments ( 12, 13) . They are located at the interface of basal epithelial cells with the underlying dermis, and are presumed to function as part of an epithelial cell-substratum attachment device ( 14) . Considerable progress has recently been made in unraveling the molecular composition of HD (12) . Domains of the bullous pemphigoid antigens 1 (BPA Gl ) and 2 (BPA G2) (15, 16) and those ofa 200-kD polypeptide ( 17) (27) . The novel laminin variant, K-laminin containing 220-kD B 1 and 210-kD B2 laminin chains, as well as a 1 90-kD novel chain, is also associated with these hemidesmosomal structures (32). Less well-characterized anchoring filament components are the protein epiligrin and the 19-DEJ-1 (33, 34) . Epiligrin antibodies precipitate peptides with electrophoretic migrations similar to those ofboth nicein / kalinin and K-laminin (35) . The molecular mass of the 19-DEJ-1 antigen is unknown (34) .
No large scale abnormalities in the BPA G1 gene were found by Southern analysis of H-JEB genomic DNA (36) . Immunohistological studies have demonstrated that a6f34 (37) is normally expressed by H-JEB basal keratinocytes. a6f4 nevertheless appears more defocalized at central basal areas of the cells (38) . On the contrary, the expression of nicein/kalinin is dramatically altered (39) (40) (41) (42) . Antibodies directed against nicein do not react with the epidermal basement membranes of most of H-JEB patients and abnormal staining can also be observed in the non-H-JEB patients (40, 41 ). Indirect immunofluorescence studies of H-JEB skin using polyclonal antibodies (pAbs) to the individual purified subunits ofnicein suggest that the protein is present but structurally altered (43) . However, because of the cross-reactivity between pAbs directed against the nic B2 and nic A subunits, the cause underlying the undetectability of nicein in H-JEB skin was not determined.
The availability of cDNAs encoding for the three nicein subunits allowed the production of pAbs directed against fusion proteins corresponding to the nic B2 and nic A chains of human nicein. These antibodies and the corresponding nicein cDNA probes have been used to follow the synthesis of the different chains of nicein in skin and cultured keratinocytes of H-JEB patients.
Methods
Tissues. Skin biopsies were from six H-JEB patients from five different families: two from 20-21-wk-old fetuses (Gf, F) and four from newborns (L, Gb, B, S). In all cases, H-JEB was diagnosed according to the revised criteria for subtyping EB (1) . The (43) . The mAb K 140 specific to the nic B 1 subunit of nicein/kalinin (31 ) and the mAb BM 165 specific to the nic A chain of nicein/kalinin, its 200-kD precursor (25), and to the 190-kD subunit of K-laminin have also been used (31). Nonimmune sera (normal human sera and preimmunized rabbit sera or culture medium of P3-NSl-Ag4-1 (NS 1 cell line) were used as control.
Cell culture. Split thickness epidermis was separated from dermis by dispase treatment at 370C. Keratinocytes were dissociated in trypsin 0.25% at 370C, and plated on a feeder of irradiated 3T3 cells (ICN, Costa Mesa, CA) (46) . Keratinocytes were grown in a 1:1 mixture of DMEM and Ham's F12 (GIBCO BRL, Eragny, France) containing 10% FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, 10 ,g/ml of penicillin and streptomycin, 10 ng/ml EGF, 100 pM choleratoxin, 400 ng/ml hydrocortisone, 5 ,ug/ml transferrin, 180 MM adenine, and 20 pM T3 (47) . H-JEB keratinocytes were expanded after gentle dissociation in 0.05% trypsin, 0.02% EDTA.
Radioimmunoprecipitation assays. Primary keratinocytes (0.6 X 106 cell/well) were seeded in 9-cm2-well plates and allowed to attach for 12 h. Cells were then labeled for 24 h in 1. (3 1 ), and then with RIPA buffer containing 0.5 M NaCl, and rinsed once with TBS. Immunoprecipitated materials were then analyzed on a 6% SDS-PAGE gel electrophoresis (48) .
Northern blot analysis. Total RNA was prepared from H-JEB and normal cultured keratinocytes according to the method of Schomczyski and Sacchi (49) . RNA was subjected to electrophoresis on 1.2% denaturing agarose gels containing 1.2 M formaldehyde and transferred onto nylon membrane (Hybond N; Amersham International). Membranes were subsequently hybridized at high stringency with 32P-labeled cDNA probes corresponding to the different chains of nicein and then exposed 16 h on Hyperfilm MP (Amersham International) with intensifying screens.
The radiolabeled cDNA probes PCR 1.3 (27) , KAL-5.5C (28) , and NA 1 (29) were used to detect the mRNA for the nic B2, nic B 1, and nic A chains, respectively.
Results
Immunohistochemical detection ofnicein chains in normal and H-JEB tissues. Immunofluorescence experiments were performed on samples ofhuman epidermis using pAbs specifically directed against each single chain of nicein ( Fig. 1 and Table I skin, all the antibodies labeled the epidermal basement membrane ( Fig. 1, A-C) . In most basal keratinocytes, pAb Pa 125 (nic Bl) (Fig. 1 B) and pAb SE 85 (nic A) ( Fig. 1 A) gave a cytoplasmic staining, whereas pAb SE 144 (nic B2) reacted more faintly with the cytoplasm of only some of the basal cells (Fig. 1 C) . Results obtained with patients Gb and Gf were consistent with observations made on patient F. Patients A and L had similar patterns ofreactivity to the antinicein antibodies. Patient S presented a distinct immunological reactivity. Representative results are shown in Fig. 1, D-I . In patients Gb, Gf, and F, the pAb Pa 125 (nic B 1 ) failed to react with both the dermal-epidermal junction and the cytoplasm ofepidermal keratinocytes, while staining with the pAbs SE 144 (nic B2) and SE 85 (nic A) was indistinguishable from that of normal controls, with the exception of the cytoplasmic staining, which was markedly stronger (Fig. 1, D and F) . This result suggests an impairment ofthe synthesis and / or the secretion of the nic B1 chain, since the other chains of nicein are apparently normally expressed. Tissue from patients A and L exposed to pAb SE 144 (nic B2) showed no immunoreactivity (Fig. 1 !) . pAb Pa 125 (nic B 1) also did not label the epidermal basement membrane of these patients, but presence of the nic B 1 subunit was detected in isolated basal keratinocytes in patient A (Fig. 1 H) . In both patients, the expression ofthe heavy chain (nic A) of nicein was comparable to that of healthy controls (Fig. 1 G) . Clearly, in these two cases only the expression ofthe nic B2 chain was completely absent. Both the pAbs SE 85 (nic A) (Fig. 1 J) and Pa 150 (nic A) (data not shown) did not reveal any specific staining; a cytoplasmic reactivity was obtained with pAb Pa 125 (nic Bl ) (Fig. 1 K) and pAb SE 144 (nic B2) (Fig. 1 L) , which indicates a low rate of synthesis of the light chains ofnicein. Thus, in this case, only the expression of the nic A chain is undetectable. All other antibodies tested (see Methods) stained the epidermal basement membrane normally (data not shown).
Expression of nicein mRNA in H-JEB keratinocytes. To check whether the altered expression of nicein subunits detected by immunofluorescence reflected possible structural alterations of nicein chains or absence of nicein chains, the expression of nicein genes was examined by Northern blot analysis of mRNA purified from primary cultures of keratinocytes obtained from the six H-JEB patients. Total mRNA was fractionated by agarose gel electrophoresis, blotted onto nitrocellulose, and subsequently hybridized to the nick-translated nicein cDNA probes.
Consistent with the immunofluorescence observations in patients Gb and F, the probe specific for nic B 1 chain failed to detect the corresponding mRNA, whereas the nic B2 chain and nic A chain mRNA were normally expressed (Fig. 2) . How- ever, the nic B1 chain mRNA could be detected as a very faint band of 4 kb in cultured keratinocytes from an affected fetus (Gf) of the G family (Fig. 2 B) . This suggests that its lack of detection in the other patient ofthe G family (Gb) was due to a strong decrease in transcription or mRNA stability rather than to a total absence. These results not only confirmed the immunofluorescence observations, indicating a possible altered expression of the nic B 1 chain, but they further demonstrated an impairment of transcription or/and an instability of the mRNA.
In the case ofpatient A and consistent with immunofluorescence data, the messengers corresponding to the chains nic B 1 and nic A were normally expressed as strong bands of 4 and 6 kb, respectively, while the nic B2 mRNA were undetectable (Fig. 2 C) . In patient L, where antibodies to the nic B2 and nic B1 chains gave no immunoreactivity, only the nic B2 chain mRNA was not detected. Thus, Northern blot analysis and morphologic observations both demonstrate that the synthesis of the nic B2 chain is specifically impaired in these two cases.
In patient S, the mRNA corresponding to all the three chains of nicein were present, but the mRNA for the nic A chain was greatly reduced (Fig. 2 A) , whereas the expression of the mRNA for the other two chains appeared normally expressed. No appreciable changes in the size of the different mRNA were seen. Synthesis ofnicein chains. In normal human keratinocytes (Fig. 3, lanes 2 and 3) , mAb K 140 (nic Bl ) and pAb SE 144 (nic B2) immunoprecipitate the mature form of nicein present in conditioned culture media, as documented by the detection of the three subunits of the protein at the molecular masses of 105, 140, and 160 kD, respectively, which approximate those previously reported for the mature forms of nicein and kalinin.
A faint band at 150 kD was also present, consistent with unprocessed B2 chain previously reported (27) . An additional band at 250 kD was visible in all the samples including controls. The bands corresponding to the nicein subunits were not observed when radioimmunoprecipitation was performed with the control preimmune serum (Fig. 3, lane 1) , while the band at 250 kD was clearly detectable in control sample from H-JEB keratinocytes from all the five patients studied (patients L and Gf; Fig. 3 , lanes 4 and 7; not shown for the three other patients) and, faintly, in normal keratinocytes. It was thus concluded that the 250-kD band is nonspecific and presumably be due to fibronectin. In patient L, mAb K 140 immunoprecipitated four polypeptides of 200, 185, 160, and 138 kD. Consistent with the results of Northern blot analysis, the 105-kD nic B2 chain was not detectable. In parallel radioimmunoprecipitation assays performed with pAb SE 144, which recognizes the nic B2 subunit, no specific band was immunoprecipitated (Fig. 3, lane 6) . A similar immunoprecipitation pattern was observed in experiments with cultured keratinocytes from the patient A (data not shown). These data definitely confirm that in these patients synthesis of nic B2 chain is impaired.
In patient Gf, the mAb K 140 specific to the nic B 1 subunit, whose mRNAs are undetectable in keratinocytes from this indi- (Fig. 3) .
Only the band corresponding to the nic B 1 chain at 140 kD was not detectable. A similar pattern was observed with patient F (data not shown). The involvement of the Nic B1 was thus clearly demonstrated.
In patient S, where no immunoreactivity was observed at the dermal-epidermal junction, whatever the antibody used, while pAb SE 144 (nic B2) and Pa 125 (nic B I) detected a cytoplasmic staining in basal keratinocytes (Fig. 1, J-L) , both pAb 144 (nic B2) and mAb 140 (nic B I) immunoprecipitated the three nicein chains. As in the other H-JEB patients, the bands corresponding to the nicein chains were reduced in intensity, compared with the counterparts from healthy donors. In all cases bands similar to those found in the culture medium were seen in the cell extract from the H-JEB keratinocytes (not shown).
Discussion
We previously reported that most H-JEB patients present a widespread defect of nicein. This was demonstrated by the lack ofreactivity ofH-JEB skin and epithelia to the mAb GB3 (41 ) . Since nicein could not be immunoprecipitated from cultured H-JEB keratinocytes with these antibodies, it was suggested that the abnormal expression of the protein could result from intrinsic defects of H-JEB epithelial cells (41 ) . The molecular 3) and H-JEB keratinocytes from patients L (lanes 4-6) and Gf (lanes 7-9) were labeled for (Table II) . It can thus be concluded that in H-JEB the impaired expression of a mature nicein is consequent to a defective synthesis of one of its subunits and that the dermatosis is genetically heterogeneous. This finding is not unexpected considering the fact that nicein comprises three different subunits synthesized by distinct genes.
In the case of patients where the absence of one of the light subunits of nicein was documented by immunofluorescence and Northern blot analysis, immunoprecipitation of keratinocyte culture medium always confirmed the absence ofsynthesis ofthe polypeptide, while secreted forms ofproteins with electrophoretic migration corresponding to the other two subunits were always identified. Other aberrant nicein proteins were also specifically recognized by the antinicein antibodies, but the corresponding bands presented abnormal electrophoretic migration patterns, different from those expected for nicein subunits. In one case (patient S), the pathology was associated with a lack of immunoreactivity to the anti-nic A antibody. This correlated with a decrease in the steady state level of the corresponding mRNA. Immunoprecipitation of culture medium conditioned by the keratinocytes ofthis patient with antibodies to the light chains of nicein detected large amounts of the three chains of nicein. It is thus clear that all the three chains are produced and secreted as a complex in this patient. Because the apparent molecular mass ofeach subunit is consistent with what is expected, conditions may exist in vivo, but not in culture, that account for instability or degradation ofthe nic A chain leading to undetectability in the skin.
Our results show no appreciable changes in the size of nicein mRNAs in any ofthe H-JEB families. In patients affected in the expression of one of the light chains of nicein, the amount of the corresponding messenger was dramatically low. Whether the abnormal concentration of such mRNAs is due to a decrease in the synthesis or to a higher decay rate has not been determined. Among the reasons that could lead to such a situation, one should consider the presence of mutations in the promoter regions of the affected gene, a decreased stability of the transcript due to mutations affecting splicing sites, nonsense mutations occurring before the penultimate exon (50), or mutations/alterations of regulatory genes ( 51 ) .
Nicein is a laminin-like molecule. It has been demonstrated from in vitro analysis ofpurified fragments that laminin assembly involves the formation of a stable coiled-coil B l-B2 intermediate to which the A chain subsequently interacts to form a more stable triple coiled-coil molecule (52) . It has not yet been determined ifthe assembly of nicein and laminin are analogous processes, but the finding that a complex formed by a heavy chain and a light chain of nicein are immunoprecipitated from the culture medium of H-JEB keratinocytes suggests that, contrary to the model proposed for laminin, in the case of nicein formation of a B l-B2-like dimer, it is not a prerequisite for extracellular secretion. However, from immunoprecipitation data, the presence of a truncated third chain of nicein in H-JEB cells cannot be formally excluded, but, considering the results of the Northern blot analysis, this possibility seems unlikely. On the other hand, a release of a dimer in the culture medium consequent to cell lysis cannot be ruled out.
The nic A chain seems to interact indifferently with either nic B1 or nic B2, because in patients L and Gf this chain appears assembled either with the nic B1 chain or the nic B2 chain, respectively. A complex missing a light chain seems, nevertheless, unstable. In fact, the amount of immunoreactive protein detected at the dermal-epidermal junction of biopsies from patients A, L, Gf, and F is exceedingly low compared with normal controls. However, the amount of nicein chains immunoprecipitated from keratinocyte medium conditioned by keratinocytes of these patients was almost comparable to that of normal keratinocytes. Moreover, a degradation of the heterodimers is suggested by the immunoprecipitation of peptides with electrophoretic migrations different from those found in medium conditioned by normal cells. For instance, the cells from patients Gf and L synthesize two polypeptides with an apparent molecular mass of 175 / 180 and 200 kD, which are sizes comparable to those of the precursor of the A chain of nicein (31). The relative abundance of these two proteins could be explained by an impairment of the maturation process and/or an inefficient excretion, either as monomers or as dimeric complexes involving the another chain of nicein. This would also explain the presence of the intracellular fluorescence found in H-JEB keratinocytes using antibodies to nic BI and nic A. These studies clearly demonstrate the involvement of nicein in the pathogenesis of H-JEB and support the idea that genes for nicein are the candidate for this disorder. However, involvement of other molecules in the etiology of the disease cannot be excluded, since abnormal expression of 19 DEJ-1 antigen has also been observed in patients affected by H-JEB and non-H-JEB subtypes. Further evidence favoring the involvement of nicein in this disorder will be provided by the linkage analysis in the kindreds of the patients studied in this work.
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